Current Perceptions and Practices Surrounding the Recognition and Treatment of Delirium in the Intensive Care Unit: A Survey of 250 Critical Care Pharmacists from Eight States

Abstract

Spanish

French

Background:

Pharmacists are key members of the intensive care unit (ICU) team; however, few data exist regarding their clinical role, perceptions, and current practices in recognizing and managing delirium.

Objective:

To describe current practices and perceptions of ICU pharmacists regarding delirium recognition and treatment relative to current recommendations.

Methods:

A self-administered survey was distributed to 457 pharmacists in 8 states who are members of the Society of Critical Care Medicine or the American College of Clinical Pharmacy and who spend 25% or more of their time providing clinical ICU pharmacy services.

Results:

A total of 250 (55%) pharmacists responded. A delirium screening tool was routinely used by few (7%) pharmacists. Lack of time (34%) and the belief that screening is a nursing role (24%) were key barriers to pharmacist screenings. Most (85%) said that delirium should be pharmacologically managed; 66% responded that 2 or more medications should be used. The treatments of first choice included Haloperidol (76%), an atypical antipsychotic (14%), or a benzodiazepine (10%). Frequently used treatments were Haloperidol (87%), quetiapine (59%), and lorazepam (47%). Haloperidol was perceived by many (42%) to have 1 or more randomized trials supporting its use for delirium and Food and Drug Administration approval for this indication (34%). Haloperidol was most often administered on a scheduled basis (62%), intravenously (92%), and al a daily dose of 5–10 mg (58%). While the QTc interval was frequently measured at least once per shift using an electrocardiogram strip (64%), it was not routinely measured in 20% of ICUs, and 60% continued haloperidol when the QTc exceeded 500 msec.

Conclusions:

Current practices and perceptions surrounding recognition and treatment of delirium in patients in the ICU by the critical care pharmacists surveyed are heterogeneous. Antipsychotics are frequently recommended by pharmacists for delirium treatment, despite a lack of rigorous evidence to support their use. While pharmacists are ideally suited to lead delirium recognition efforts and provide treatment recommendations in this area, these roles need further elucidation. The optimal pedagogical strategy to support these efforts remains unclear, and the potential impact of pharmacists’ efforts on patients’ outcomes is unknown.

Keywords

antipsychotic delirium haloperidol intensive care pharmacist practice patterns quetiapine

Get full access to this article

View all access options for this article.

References

American Psychiatric Association: task force on DSM-IV. DSM-IV sourcebook. 1st ed. Washington, DC: American Psychiatric Press, 1994.

Skrobik

. Delirium prevention and treatment. Crit Care Clin 2009; 25:585–91.

Ely

, Shintani

, Truman

. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291:1753–62.

Pisani

, Kong

, Kasl

, Murphy

, Araujo

, Van Ness

. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009; 180:1092–7.

Ely

, Gautam

, Margolin

. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001; 27:1892–900.

Girard

, Jackson

, Pandharipande

. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010; 38:1513–20.

Jacobi

, Fraser

, Coursin

. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119–41.

Borthwick

, Bourne

, Craig

, Egan

, Oxley

. United Kingdom Clinical Pharmacy Association: detection, prevention and treatment of delirium in critically ill patients, http://www.ics.ac.uk/intensive_care_professional/standards_and_guidelines/ukcpa_delirium_2006 (accessed 6 Apr 2011).

National Institute for Health and Clinical Excellence. Delirium guidelines. http://guidance.nice.org.uk/CG103 (accessed 6 Apr 2011).

10.

Martin

, Heymann

, Bäsell

. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care—short version. Ger Med Sci 2010; 8:Doc02.

11.

Bergeron

, Dubois

, Dumont

, Dial

, Skrobik

. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001; 27:859–64.

12.

Ely

, Margolin

, Francis

. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001; 7:1370–9.

13.

Devlin

, Fong

, Fraser

, Riker

. Delirium assessment in the critically ill. Intensive Care Med 2007; 33:929–40.

14.

Pun

, Gordon

, Peterson

. Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers. Crit Care Med 2005; 6:1199–205.

15.

Van den Boogard

, Picckers

, van der Hoeven

. Implementation of a delirium assessment tool in the ICU can influence haloperidol use. Crit Care 2009; 13:R131. DOI 10.1186/cc7991

16.

Lin

, Russell

, Devlin

, Norton

, Evans

, Gesin

. Impact of implementing a validated delirium screening tool, with or without a multifaceted didactic and bedside educational program, on the ability of nurses to correctly assess and recognize delirium in a surgical-trauma intensive care unit. Crit Care Med 2010; 38(suppl):A203.

17.

Devlin

, Fong

, Schumaker

, O'Connor

, Ruthazer

, Garpestad

. Use of a validated delirium assessment tool improves the ability of physicians to identify delirium in medical intensive care unit patients. Crit Care Med 2007; 35:2721–4.

18.

Devlin

, Marquis

, Riker

. Combined didactic and scenario-based education improves the ability of intensive care unit staff to recognize delirium at the bedside. Crit Care 2008; 12:R19. DOI 10.1186/CC6793

19.

Ely

, Stephens

, Jackson

. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004; 32:295–6.

20.

Devlin

, Fong

, Howard

. Assessment of delirium in the intensive care unit: nursing practices and perceptions. Am J Crit Care 2008; 17:555–65.

21.

Van Eijk

, Kesecioglu

, Slooter

. Intensive care delirium monitoring and standardised treatment: a complete survey of Dutch intensive care units. Intensive Crit Care Nurs 2008; 24:218–21.

22.

Cheung

, Alibhai

, Robinson

. Recognition and labeling of delirium symptoms by intensivists: does it matter? Intensive Care Med 2008; 34:437–46.

23.

Shehabi

, Botha

, Boyle

. Sedation and delirium in the intensive care unit: an Australian and New Zealand perspective. Anaesth Intensive Care 2008; 36:570–8.

24.

Patel

, Gambrell

, Speroff

. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 2009; 37:825–32.

25.

Cadogan

, Riekerk

, Vreeswijk

. Current awareness of delirium in the intensive care unit: a postal survey in the Netherlands. Neth J Med 2009; 67:296–300.

26.

Mac Sweeney

, Barber

, Page

. A national survey of the management of delirium in UK intensive care units. QJM 2010; 103:243–51.

27.

Forsgren

, Eriksson

. Delirium—awareness, observation and interventions in intensive care units: a national survey of Swedish ICU head nurses. Intensive Crit Care Nurs 2010; 26:296–303.

28.

Devlin

, Skrobik

. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role? Harv Rev Psychiatry 2011; 9:1–9.

29.

American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999; 156:1–20.

30.

Food and Drug Administration. Information for healthcare professionals: haloperidol 2009. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085203.htm (accessed 2011 May 11).

31.

Devlin

, Roberts

, Fong

. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38:419–27.

32.

Girard

, Pandharipande

, Carson

. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010; 38:428–37.

33.

Reade

, O'Sullivan

, Bates

, Goldsmith

, Ainslie

, Bellomo

. Dexmedetomidine vs haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009; 13:R75. DOI 10.11867cc7890

34.

Skrobik

, Bergeron

, Dumont

, Gottfried

. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004; 30:444–9.

35.

Lonergan

, Luxenberg

, Areosa Sastre

, Wyller

. Benzodiazepines for delirium. Cochrane Database Syst Rev 2009; 1:CD006379.

36.

Kane

, Weber

, Dasta

. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 2003; 29:691–8.

37.

MacLaren

, Bond

. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic- or infarction-related events. Pharmacotherapy 2009; 29:761–8.

38.

Marshall

, Finn

, Theodore

. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med 2008; 36:427–33.

39.

Devlin

, Nasraway

Jr . Reversing oversedation in the intensive care unit: the role of pharmacists in energizing guideline efforts and overcoming protocol fatigue. Crit Care Med 2008; 36:626–8.

40.

Maclaren

, Devlin

, Martin

, Dasta

, Rudis

, Bond

. Critical care pharmacy services in United States hospitals. Ann Pharmacother 2006; 40:612–8. DOI 10.1345/aph.1G590

41.

Marquis

, Ouimet

, Riker

, Cossette

, Skrobik

. Individual delirium symptoms: do they matter? Crit Care Med 2007; 35:2533–7.

42.

Pandharipande

, Ely

. Sedative and analgesic medications: risk factors for delirium and sleep disturbances in the critically ill. Crit Care Clin 2006; 22:313–27.

43.

Maldonado

, Wysong

, van der Starre

, Block

, Miller

, Reitz

. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Pychosomatics 2009; 50:206–17.

44.

Pisani

, Murphy

, Araujo

, Van Ness

. Factors associated with persistent delirium after intensive care unit admission in an older medical patient population. J Crit Care 2010; 25:540–7.

45.

Devlin

, Skrobik

, Riker

. Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a double-blind, randomized, placebo-controlled pilot study. Crit Care Med 2010; 38(suppl):A880.

46.

Spronk

, Riekerk

, Hofhuis

, Rommes

. Occurrence of delirium is severely underestimated in the ICU during daily care. Neth J Med 2009; 35:1276–80.

47.

Skrobik

. Haloperidol should be used sparingly. Crit Care Med 2002; 30:2612–4.

48.

Devlin

, Mallow-Corbett

, Riker

. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 2010; 38:S231–43.

49.

Sharma

, Rosman

, Padhi

, Tisdale

. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81:238–40.

50.

Product information. Haldol (haloperidol). Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc, February 2008.

51.

Food and Drug Administraiton. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085203.htm (accessed 2011 May 11).

52.

TMH

, Bell

, Hong

. Pharmacist monitoring of QTc interval-prolonging medications in critically ill patients: a pilot study. Ann Pharmacother 2008; 42:475–82. DOI 10.1345/aph.1K458

53.

Drew

, Ackerman

, Funk

. Prevention of torsade de points in hospital settings. A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010; 121:1047–60.

54.

Wang

, Schneeweiss

, Avorn

. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 2005; 353:2335–41.

55.

Devlin

, Nava

, Fong

, Bahhady

, Hill

. Survey of sedation practices during noninvasive positive-pressure ventilation to treat acute respiratory failure. Crit Care Med 2007; 35:2298–302.